Kevin G Lafond - Net Worth and Insider Trading

Kevin G Lafond Net Worth

The estimated net worth of Kevin G Lafond is at least $1,039 dollars as of 2024-11-13. Kevin G Lafond is the SVP, Treasurer & CAO of Alaunos Therapeutics Inc and owns about 426 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $1,039. Details can be seen in Kevin G Lafond's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin G Lafond has not made any transactions after 2021-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kevin G Lafond

To

Kevin G Lafond Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin G Lafond owns 1 companies in total, including Alaunos Therapeutics Inc (TCRT) .

Click here to see the complete history of Kevin G Lafond’s form 4 insider trades.

Insider Ownership Summary of Kevin G Lafond

Ticker Comapny Transaction Date Type of Owner
TCRT Alaunos Therapeutics Inc 2021-01-08 Vice Pres. & Treasurer & & CAO

Kevin G Lafond Latest Holdings Summary

Kevin G Lafond currently owns a total of 1 stock. Kevin G Lafond owns 426 shares of Alaunos Therapeutics Inc (TCRT) as of January 8, 2021, with a value of $1,039.

Latest Holdings of Kevin G Lafond

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TCRT Alaunos Therapeutics Inc 2021-01-08 426 2.44 1,039

Holding Weightings of Kevin G Lafond


Kevin G Lafond Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin G Lafond has made a total of 3 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Alaunos Therapeutics Inc is the sale of 120 shares on January 8, 2021, which brought Kevin G Lafond around $55,682.

Insider Trading History of Kevin G Lafond

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin G Lafond Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kevin G Lafond Ownership Network

Ownership Network List of Kevin G Lafond

No Data

Ownership Network Relation of Kevin G Lafond

Insider Network Chart

Kevin G Lafond Owned Company Details

What does Alaunos Therapeutics Inc do?

Who are the key executives at Alaunos Therapeutics Inc?

Kevin G Lafond is the Vice Pres. & Treasurer & & CAO of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .

Alaunos Therapeutics Inc (TCRT) Insider Trades Summary

Over the past 18 months, Kevin G Lafond made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,

In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.

Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alaunos Therapeutics Inc Insider Transactions

No Available Data

Kevin G Lafond Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin G Lafond. You might contact Kevin G Lafond via mailing address: C/o Helicos Biosciences Corporation, 1 Kendall Square, Building 700, Cambridge Ma 02139.